MedTach

What MedTach does

MedTach Inc. (operating as MedTach Medical Technologies) is a privately held Canadian medical device distributor headquartered in Burlington, Ontario, founded in 2013 by Greig Findley (President and CEO) and Cheryl Findley (General Manager). The company functions as the Canadian channel for a curated portfolio of research-grade human physiology measurement systems, serving university labs, research hospitals, clinical research organizations, and selected applied healthcare facilities in Canada. MedTach does not manufacture its own devices; instead, it distributes and supports third-party instruments from Finapres (continuous non-invasive blood pressure via Volume-Clamp finger cuff technology), VICORDER/SMT Research (vascular function and arterial stiffness), Delica (transcranial Doppler), Bittium Faros and Schiller (ECG and ambulatory blood pressure monitoring), Caretaker (wireless ICU-grade vital signs), Kinesis QTUG (mobility/fall risk), TempTraq, FIAB, and Carrot.

The company's commercial model is B2B and sales-led, with quote-based pricing on all product pages, "Speak with a Specialist" consultation CTAs, and modular hardware (Basic, ECG+RESP, Full Option) and software (Guided Autonomic Testing, Advanced Hemodynamics, Autonomic Testing, Nova Scope PC, Remote Control) configurations on the flagship Finapres NOVA PLUS platform. Revenue is generated primarily through one-time hardware sales, supplemented by subscription-style software module revenue and ongoing technical support, onboarding, training, and lab continuity services. The portfolio is organized solution-first by measurement area — hemodynamics, vascular function, cerebral blood flow, cardiac electrophysiology, and autonomic function — and many of the underlying technologies carry EU CE and US FDA certifications, though some (e.g., VICORDER) are research-use-only in Canada due to the absence of Health Canada listing.

Strategically, MedTach is a niche specialist distributor whose differentiation is concentrated in curated brand access, regulatory-validated instrumentation, and high-touch lab support, rather than in proprietary technology, software platforms, or proprietary data assets. With 1-10 employees, Canada-only geography, founder ownership, no disclosed external funding, and no disclosed revenue, the business operates at a small scale with modest structural barriers and meaningful dependence on continued manufacturer distribution relationships.

Name

MedTach

Legal name

MedTach Inc.

Website

https://medtach.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

MedTach is a privately held Canadian medical device distributor that supplies research-grade human physiology measurement systems — including Finapres continuous blood pressure, VICORDER vascular testing, Delica transcranial Doppler, Bittium ECG, and Schiller ABPM — to university labs, clinical research organizations, and applied healthcare facilities across Canada.

Ownership category

akta.pro rank

Product category

Medical Device Distribution and Human Physiology Monitoring Systems

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Continuous Temperature & Fever Monitoring (Wearable Thermometry) (HLAHACAK)

Keywords

• Medical device distribution
• Human physiology monitoring
• Cardiovascular diagnostics
• Vascular assessment systems
• Non-invasive patient monitoring

Headquarters

HQ city

Burlington

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Device Hardware Sales: MedTach generates revenue primarily through the sale of research-grade human physiology measurement equipment including Finapres NOVA systems, VICORDER, Delica TCD, Bittium Faros ECG, and related accessories. Hardware configurations are sold as packages with various option levels.
2. Software Licenses and Applications: Revenue from expandable software modules for Finapres NOVA including Guided Autonomic Testing (GAT), Advanced Hemodynamics, Autonomic Testing, Nova Scope PC, and Remote Control applications.
3. Technical Support and Training Services: Ongoing support programs including onboarding, training, technical support, and lab continuity services designed to maintain performance across staff turnover and long-term studies.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

MedTach is a Canadian distributor of research-grade, non-invasive human physiology measurement systems serving labs and clinics across Canada. The company distributes validated medical devices from leading manufacturers covering continuous blood pressure monitoring (Finapres), transcranial Doppler (Delica), vascular function assessment (VICORDER), wireless ICU-grade vital signs (Caretaker), ECG cardiac Holter (Bittium Faros, Schiller), ambulatory blood pressure monitoring (Schiller), mobility and fall assessment (Kinesis QTUG), temperature monitoring (TempTraq), and transesophageal cardiac pacing (FIAB), supported by onboarding, training, and lab continuity programs.

Product overview

MedTach provides a comprehensive portfolio of research-grade human physiology measurement systems for Canadian labs and clinics. The offering is organized as a platform approach centered around the Finapres Nova Plus system — an innovative hemodynamic monitoring platform that provides continuous non-invasive blood pressure monitoring via finger cuff technology and can be expanded with modular hardware configurations (Basic, ECG + RESP, Full Option) and software applications (Guided Autonomic Testing, Advanced Hemodynamics, Autonomic Testing, Nova Scope, Remote Control). Complementing this core hemodynamic platform, MedTach distributes specialized monitoring technologies including: Delica Transcranial Doppler for cerebral blood flow measurement, VICORDER for vascular function and arterial stiffness research, Caretaker wireless ICU-grade vital signs monitoring with VitalStream, TempTraq fever detection patches, Bittium Faros ECG cardiac Holter solutions (including waterproof ECG, Cardiac Navigator analysis, HolterPlus remote monitoring, and Cardioscope autonomic testing), Schiller ambulatory BP monitoring and cardiac Holter devices, Kinesis mobility and fall probability assessment tools (QTUG, gait, balance), Carrot C-Com wireless headsets, and FIAB transesophageal cardiac pacing systems. The company supports these technologies with technical training, onboarding, system optimization, and lab continuity programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Finapres Nova Plus

Quantifiable outcome

• VICORDER has been validated against gold standard practices and proven in >100 studies with high reproducibility.
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Ten partnerships are on record, tiered core and secondary.

• FinaprescoreTechnology or IntegrationMedTach distributes Finapres NOVA PLUS products, an innovative hemodynamic monitoring system providing accurate non-invasive continuous blood pressure monitoring. Finapres is the manufacturer of the Volume-Clamp technology and related measurement systems. MedTach serves as the Canadian representative for this technology.
• DelicacoreTechnology or IntegrationMedTach distributes Delica Transcranial Doppler systems for real-time measurement of cerebral blood flow velocity and brain circulation in the Canadian market.
• VICORDER (SMT Research)coreTechnology or IntegrationMedTach distributes VICORDER, a non-invasive vascular testing solution for arterial stiffness and peripheral arterial disease. VICORDER has received EU CE certification and US FDA certification.
• BittiumcoreTechnology or IntegrationMedTach distributes Bittium Faros ECG cardiac Holter devices, including waterproof ECG solutions, Holter analysis, and autonomic testing applications.
• SchillercoreTechnology or IntegrationMedTach distributes Schiller ABPM (Ambulatory Blood Pressure Monitoring) and Cardiac Holter products including BR-102 plus PWA, BR-102 plus, medilogAR ECG Holter, and Cardiovit FT1.
• KinesissecondaryTechnology or IntegrationMedTach distributes Kinesis mobility and fall probability technology including QTUG, gait analysis, and balance assessment solutions.
• Caretaker MedicalcoreTechnology or IntegrationMedTach distributes Caretaker wireless ICU-grade vital signs monitoring systems including VitalStream and virtual hospital monitoring capabilities.
• TempTraqsecondaryTechnology or IntegrationMedTach distributes TempTraq real-time fever detection patch technology for continuous temperature monitoring.
• FIABsecondaryTechnology or IntegrationMedTach distributes FIAB transesophageal cardiac pacing equipment including ESO TEMP monitor and ESO leads.
• CarrotsecondaryTechnology or IntegrationMedTach distributes Carrot C-Com wireless headset technology for physiological monitoring applications.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• BIOPAC Systems: Provides physiology data acquisition and analysis systems (MP160, AcqKnowledge) for academic, clinical research, and life-science applications. Directly comparable product category and customer base to MedTach's research-grade physiology monitoring portfolio.
• ADInstruments: Manufactures research-grade physiology data acquisition systems (PowerLab, LabChart) widely used in university and clinical research labs globally. Comparable because they serve the same cardiovascular, autonomic, and physiology research customer base with similar product categories that MedTach distributes via Finapres, Bittium, and VICORDER.
• Compumedics: Designs and manufactures sleep, neuro, and cardiac monitoring systems used in clinical and research environments. Comparable because of overlap with MedTach's cerebral blood flow (Delica TCD), autonomic, and cardiac electrophysiology product lines.
• iWorx Systems: Provides physiology teaching and research equipment (iWorx RA, IX-TA) to universities and research labs. Comparable because it targets the same academic and human physiology research customers MedTach serves, with similar non-invasive measurement categories (BP, ECG, EMG).
• Thought Technology: Canadian (Montreal-based) manufacturer of biofeedback, psychophysiological, and physiological monitoring equipment. A particularly apt peer given the Canadian base and overlapping focus on validated, non-invasive human physiology measurement in research and clinical settings.
• Noraxon: Manufactures human movement science, biomechanics, and physiology monitoring systems (myomotion, EMG, ECG) for research, sports, and clinical applications. Directly comparable in product category and research/clinical customer base.

Broad incumbents

• Medtronic: Broad cardiovascular, cardiac rhythm management, and neurology medical device company. CEO Greig Findley's prior work history explicitly spans Medtronic-product categories (CRM, DBS, SCS), and Medtronic's breadth overlaps with multiple MedTach product lines at the device category level.
• Masimo: Patient monitoring and vital signs technology company (SET pulse oximetry, rainbow parameters, continuous non-invasive monitoring). Comparable because Masimo competes in non-invasive vital signs monitoring — adjacent to MedTach's Caretaker and TempTraq offerings.
• Edwards Lifesciences: Major hemodynamic monitoring incumbent (FloTrac, ClearSight non-invasive BP using Volume-Clamp-derived technology). Particularly comparable because Edwards acquired Finapres-related IP and competes in adjacent non-invasive hemodynamic monitoring — a structural competitive threat to MedTach's Finapres line in clinical settings.
• Philips Patient Monitoring: Broad patient monitoring portfolio including hemodynamic, vital signs, and ICU monitoring in clinical environments. Comparable at the technology category level but operates as a much larger diversified incumbent spanning the same measurement domains.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medtach

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedTach